Siegfried Holding AG operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Siegfried Holding AG with three other
pharmaceutical manufacturers in Europe:
sales of 885.53 million Bulgarian Lev [US$497.21 million]
of which 52%
of the United Kingdom
(£367.80 million [US$452.40 million]
of which 36%
was Licensing & Biotechnology), and
Synergy Health Plc
based in the United Kingdom
(£408.82 million [US$502.86 million]
of which 43%
was Hospital Sterilisation Services).
Siegfried Holding AG reported sales of 480.57 million Swiss Francs (US$485.42 million)
December of 2015.
increase of 52.4%
versus 2014, when the company's sales were 315.28 million Swiss Francs.
Sales of Drug Products saw an increase
82.4% in 2015, from
80.80 million Swiss Francs to 147.40 million Swiss Francs.